BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 7862847)

  • 1. An examination of the behavioural specificity of hypophagia induced by 5-HT1B, 5-HT1C and 5-HT2 receptor agonists using the post-prandial satiety sequence in rats.
    Kitchener SJ; Dourish CT
    Psychopharmacology (Berl); 1994 Jan; 113(3-4):369-77. PubMed ID: 7862847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence that hypophagia induced by mCPP and TFMPP requires 5-HT1C and 5-HT1B receptors; hypophagia induced by RU 24969 only requires 5-HT1B receptors.
    Kennett GA; Curzon G
    Psychopharmacology (Berl); 1988; 96(1):93-100. PubMed ID: 2906446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin 1B and 2C receptor interactions in the modulation of feeding behaviour in the mouse.
    Dalton GL; Lee MD; Kennett GA; Dourish CT; Clifton PG
    Psychopharmacology (Berl); 2006 Mar; 185(1):45-57. PubMed ID: 16470405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT2 receptor agonist MK-212 reduces food intake and increases resting but prevents the behavioural satiety sequence.
    Halford JC; Lawton CL; Blundell JE
    Pharmacol Biochem Behav; 1997 Jan; 56(1):41-6. PubMed ID: 8981607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT1B receptor agonist CP-94,253 reduces food intake and preserves the behavioural satiety sequence.
    Halford JC; Blundell JE
    Physiol Behav; 1996 Sep; 60(3):933-9. PubMed ID: 8873272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin 2C receptor agonists and the behavioural satiety sequence in mice.
    Hewitt KN; Lee MD; Dourish CT; Clifton PG
    Pharmacol Biochem Behav; 2002 Apr; 71(4):691-700. PubMed ID: 11888560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for involvement of 5-HT1C and 5-HT2 receptors in the food intake suppressant effects of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Aulakh CS; Hill JL; Yoney HT; Murphy DL
    Psychopharmacology (Berl); 1992; 109(4):444-8. PubMed ID: 1365860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
    Berendsen HH; Broekkamp CL
    Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of the 5-HT1C/5-5-HT2 receptor agonists DOI and alpha-methyl-5-HT on plasma glucose and insulin levels in the rat.
    Chaouloff F; Laude D; Baudrie V
    Eur J Pharmacol; 1990 Oct; 187(3):435-43. PubMed ID: 2127400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adrenodemedullation and adrenalectomy on the 5-HT2 receptor agonists DOI-and mCPP-induced hypophagia in rats.
    Yamada J; Sugimoto Y; Yoshikawa T; Horisaka K
    Neurosci Lett; 1996 May; 209(2):113-6. PubMed ID: 8761995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the behavioural specificity of hypophagia induced in male rats by mCPP, naltrexone, and their combination.
    Wright FL; Rodgers RJ
    Psychopharmacology (Berl); 2014 Feb; 231(4):787-800. PubMed ID: 24114428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
    Bervoets K; Millan MJ; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anorexia induced by M-trifluoromethylphenylpiperazine (TFMPP) in rats.
    Kłodzińska A; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1990; 42(1):13-7. PubMed ID: 2281017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC; Kitchen I
    Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of tryptophan and of 5-hydroxytryptamine receptor subtype agonists on feeding.
    Curzon G
    Adv Exp Med Biol; 1991; 294():377-88. PubMed ID: 1837683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5-HT1A, 5-HT1B and 5-HT2 receptor agonists induce differential behavioral responses in preweanling rat pups.
    Frambes NA; Kirstein CL; Moody CA; Spear LP
    Eur J Pharmacol; 1990 Jun; 182(1):9-17. PubMed ID: 2144825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infusion of the 5-hydroxytryptamine agonists RU24969 and TFMPP into the paraventricular nucleus of the hypothalamus causes hypophagia.
    Hutson PH; Donohoe TP; Curzon G
    Psychopharmacology (Berl); 1988; 95(4):550-2. PubMed ID: 3145525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurons in the hypothalamic paraventricular nucleus mediate the serotonergic stimulation of prolactin secretion via 5-HT1c/2 receptors.
    Rittenhouse PA; Levy AD; Li Q; Bethea CL; Van de Kar LD
    Endocrinology; 1993 Aug; 133(2):661-7. PubMed ID: 8344205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that mCPP may have behavioural effects mediated by central 5-HT1C receptors.
    Kennett GA; Curzon G
    Br J Pharmacol; 1988 May; 94(1):137-47. PubMed ID: 3401632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxiogenic-like effects of mCPP and TFMPP in animal models are opposed by 5-HT1C receptor antagonists.
    Kennett GA; Whitton P; Shah K; Curzon G
    Eur J Pharmacol; 1989 May; 164(3):445-54. PubMed ID: 2767117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.